18.80NOK-1.31%Mkt Cap: 449.65M NOKP/E: —Last update: 2026-05-13
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. Its product portfolio includ…
Industry Peers
Medical Distribution66.63BTRY—
6.79BSEKP/E 19.3
2.40BEURP/E 35.3
1.12BEURP/E 21.6
364.30MEURP/E 20.4
304.32MEURP/E 14.2
199.91MEURP/E 21.7
68.65MEUR—
loading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)27.99
PEG1.38
P/B1.35
P/S0.79
EV/EBITDA13.03
EV/Revenue1.01
EPS (TTM)-1.24
EPS (Forward)0.67
Cash Flow & Leverage
FCF Yield5.17%
FCF Margin4.07%
Operating CF25.59M NOK
CapEx (TTM)2.38M NOK
Net Debt/EBITDA3.11
Net Debt137.64M NOK
Technical
SMA 5019.83 (-5.2%)
SMA 20021.72 (-13.4%)
Beta0.20
S&P 52W Chg24.23%
Avg Vol (30d)12.79K
Avg Vol (10d)11.82K
Technical Indicators
RSI (14)41.0
MACD-0.3862
MACD Signal-0.3492
MACD Hist.-0.0370
BB Upper21.65 NOK
BB Middle19.59 NOK
BB Lower17.54 NOK
BB Width20.97%
ATR (14)0.6702 NOK
Vol Ratio (20d)0.29x
52W Range
18.107% of range27.90
52W High27.90 NOK
52W Low18.10 NOK
Profitability
Gross Margin38.97%
EBITDA Margin7.75%
Profit Margin-4.16%
Oper. Margin1.32%
ROE-7.05%
ROA-3.17%
Revenue Growth4.50%
Earnings Growth—
Balance Sheet
Debt/Equity0.68
Current Ratio1.47
Quick Ratio0.76
Book Value/Sh13.93 NOK
Cash/Share2.868 NOK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 NOK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateApr 13, 2010
Pay Date—
Ownership
Shares Out.23.98M
Float12.96M
Insiders28.28%
Institutions39.67%
Analyst Consensus
Rating—
Target (Mean)26.00 NOK
Target Range26.00 NOK – 26.00 NOK
# Analysts1
Company
Market Cap449.65M NOK
Enterprise Value576.39M NOK
Revenue (TTM)571.24M NOK
Gross Profit220.32M NOK
Net Income (TTM)-23.54M NOK
Revenue/Share27.89 NOK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees38
Last Price18.80 NOK
CountryNO
SectorHealthcare
IndustryMedical Distribution
ISIN—